Novita Pharmaceuticals
PrivateLast Round
Strategic
Jul 28, 2021
Total Funding Raised
$25.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Novita Pharmaceuticals is a biopharmaceutical company that develops first-in-class drugs to prevent and treat cancer metastasis and enhance anti-cancer immune responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novita Pharmaceuticals Comparables
Compare Novita Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| China Resources Pharmaceutical Group Ltd | 78% | |
| Pacylex Pharmaceuticals | 73% | |
| Cybrexa Therapeutics | 72% | |
Novita Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 28, 2021 | ||||
| Debt | Oct 16, 2020 | ||||
| Series A | Apr 6, 2017 | ||||
| Seed | Jan 4, 2011 |
Novita Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Asia | Series A |
| Gaorong Capital | Debt, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 57% MoM, reaching 2.9K.
- Jul 28, 2021
$15M round led by China Resources Double-Crane Pharmaceutical
Novita Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novita Pharmaceuticals's valuation, stock price, and market status.